Mauricio Fernández, the former mayor of San Pedro Garza García, passed away on September 22, 2025, after a courageous battle with lung cancer. His death at the age of 75 marks the end of an era for a ...
Surgery has long been a standard option in treating mesothelioma, but a new survey from The Mesothelioma Center at Asbestos.com revealed that U.S. surgeons have become more selective about suggesting ...
An early phase clinical trial showed that patients with mesothelioma - a rare cancer of the lining of the lung - who received ...
New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of ...
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AstraZeneca has launched a Phase III ...
Paris, France, June 4th, 2025. Oncovita, a biotechnology company developing innovative virus-based immunotherapies for cancer treatment, today announced that the U.S. Food and Drug Administration (FDA ...
Nobody likes to talk or think about cancer, but it’s a serious disease that we should all aim to understand a little better. Better understanding the signs and symptoms of cancer, as well as how to ...
Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics ...